Massive Bio Facebook ad: “PD-L1 High NSCLC Trial”

Ran for 80 days, from July 18 to October 6, 2026, the last day Crush saw it.
Run by Massive Bio on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Make your own version of this ad
Crush makes it, launches it in your own Meta ad account, scales the winners and pauses the losers.
About this ad
- Meta Ad Library ID
- 1451645790326148
- Platforms
- Facebook, Instagram, Audience Network, Messenger and Threads
- Relaunches
- 0
Ad text
For metastatic NSCLC with PD-L1 ≥50% and no actionable mutations, a first-line clinical trial is open. Refer appropriate patients today.
Where the ad sends people
massivebio.com
PD-L1 High NSCLC Trial
PD-L1 ≥50% | No actionable mutations | Treatment-naive advanced NSCLC.'
Learn more: massivebio.com(opens in a new tab)










